What we do > Platform

RNA Platform

PLATFORM AT GREENLIGHT

An introduction to RNA

We can make multiple forms of RNA at scale using a differentiated manufacturing platform. We believe our expertise and proprietary technology will allow us to bring RNA products quickly and cost-effectively to market.

Read more

close up of bee near flowers

RNA IN ACTION

“What we’ve been able to do is actually make your RNA of choice. That allows you to make metric-ton quantities, in a capital-efficient system at a cost that the farmers can afford.”

–Carole Cobb, GreenLight COO

PLATFORM

How do we make RNA?

What is cell free production and how is ours different? The technology we developed to produce dsRNA at metric-ton scale can be leveraged and transformed, using our technical agility, for our mRNA platform.

Read more

PLATFORM

The impact of our scalable, high-quality, low-cost RNA

In Rochester, New York, we are operating the world’s largest RNA factory. Find out more on our blog about how we have sized up from the lab to industrial scale.

Read more

Gallery

Where and how

Our 17,000-square-foot facility in Rochester, New York will manufacture enzymes and RNA for a variety of agricultural applications, including the protection of honeybees.

a large sign shows company names at Rochester business park

Our plant in Rochester, New York has an installed capacity at 500 kg of RNA per year, with ready expansion to 1,000 kg.

Two men work together in a Greenlight factory to put together a pipe

The fermentation process to produce RNA has to be managed carefully to produce good field test candidates

a bee walks on a honeycomb with a varroa mite on its back

They might not be bigger than a speck of pepper, but Varroa mites can devastate bee populations.

a man stands in front of containers of yellow liquid at GreenLight's factory

We hope to use our cell-free manufacturing process to produce RNA at scale.

a pouch sits on a beehive

Pouches of our Varroa candidate are placed inside hives for bees to consume

The GreenLight way

  • Affordability

    Our proprietary cell-free methodology that enables prices as low as $1/gram for dsRNA

  • Quality

    Our system allows us to create high-quality RNA

  • Speed

    Batches take hours, not weeks, allowing us to be flexible and efficient.

PLATFORM

How our technology solves many RNA production problems

Each step and reaction component in the GreenLight bioproduction process has been developed or selected with cost, quality, safety, and commercial scalability in mind.

Read more

BECOME A PARTNER

We won’t succeed alone

We work with some of the world’s leading universities, companies, and scientists

Learn more

News and insights

The latest on GreenLight’s work and partnerships, and what the world has been saying about us.

All news
  • GreenLight’s honeybee-saving RNA solution named finalist in World Changing Ideas Award

    05.10.22


    GreenLight’s honeybee-saving RNA solution named finalist in World Changing Ideas Award
    GO!
  • International crop network validates ledprona as a new Mode of Action group

    04.05.22


    International crop network validates ledprona as a new Mode of Action group
    GO!
  • Co-developer of COVID-19 Vaccine Joins GreenLight Advisory Board

    03.29.22


    Co-developer of COVID-19 Vaccine Joins GreenLight Advisory Board
    GO!
  • EndPoints: Q&A with GreenLight CEO Andrey Zarur

    03.17.22


    EndPoints: Q&A with GreenLight CEO Andrey Zarur
    GO!
  • BioCentury: GreenLight messenger RNA shingles vaccine deal with Serum Institute of India

    03.14.22


    BioCentury: GreenLight messenger RNA shingles vaccine deal with Serum Institute of India
    GO!
  • Endpoints: GreenLight licenses mRNA shingles vaccine

    03.14.22


    Endpoints: GreenLight licenses mRNA shingles vaccine
    GO!